Interest of focal radiotherapy in case of oligoprogression under immunotherapy in the treatment of metastatic non-small cell lung cancer

CONCLUSION: The combination of focal radiotherapy in case of oligoprogression and continued treatment with nivolumab in the treatment of metastatic NSCLC in the second or subsequent line of treatment seems to be with an increase in PFS.PMID:38445648 | DOI:10.1016/j.bulcan.2023.09.006

Source: Bulletin du Cancer - March 6, 2024 Category: Cancer & Oncology Authors: Ana ïs Gagé Bruno Pereira Aur élie Belliere Henri Janicot Ga ëlle Jeannin Clara Bourrachot Muriel Durand Camille Rolland-Debord Patrick Merle Source Type: research